Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
5.13
-0.37 (-6.73%)
Nov 18, 2026, 1:01 PM EST - Market open
Phathom Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Reiterates $14 → $10 | Buy | Reiterates | $14 → $10 | +94.93% | Nov 18, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $10 → $7.5 | Hold | Maintains | $10 → $7.5 | +46.20% | Nov 2, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $22 | Buy | Reiterates | $22 | +328.85% | Oct 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $26 | Buy | Reiterates | $26 | +406.82% | Oct 30, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 23, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $20 → $15 | Buy | Maintains | $20 → $15 | +192.40% | Oct 21, 2026 |
| Raymond James | Raymond James | Buy Maintains $21 | Buy | Maintains | $21 | +309.36% | Jul 31, 2026 |
| Needham | Needham | Buy Maintains $28 → $22 | Buy | Maintains | $28 → $22 | +328.85% | Jul 30, 2026 |